This section is only updated periodically, may not be complete, and does not replace a search for the most current available data and literature!
Literature
| Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia | A retrospective cohort study analyzing over 130 FNAIT cases, investigating clinical and laboratory predictors of severe FNAIT. | Matusiak K, et al. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia. Transfusion. 2022 Nov;62(11):2213-2222. | https://pubmed.ncbi.nlm.nih.gov/36239096/ |
| Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach. | An international panel developed evidence-based recommendations for the diagnosis and management of FNAIT. | Lieberman L, et al.International Collaboration for Transfusion Medicine Guidelines (ICTMG). Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach. Br J Haematol. 2019 May;185(3):549-562. | https://pubmed.ncbi.nlm.nih.gov/30828796/ |
| Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study. | A dutch cohort study adressing the incidence of FNAIT, the impact of anti-body titers and the association of FNAIT and maternal DRB3*01:01 positivity. | de Vos TW, et al. Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study. Lancet Haematol. 2023 Dec;10(12):e985-e993. | https://pubmed.ncbi.nlm.nih.gov/38407610/ |
| Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. | Evaluates the negative predictive value of antibody titers in women at risk for FNAIT. | Kjaer M, et al. International Collaboration for Transfusion Medicine Guidelines. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Vox Sang. 2019 Jan;114(1):79-94. | https://pubmed.ncbi.nlm.nih.gov/30565711/ |
| Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: A cost-utility analysis. | A description of the Dutch approach to screen women for FNAIT and a cost-utility analysis evaluating their approach. | de Vos TW, et al. Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: A cost-utility analysis. Vox Sang. 2024 Dec 5. doi: 10.1111/vox.13779. | https://pubmed.ncbi.nlm.nih.gov/39638612/ |
Podcasts
I highly recommend this episode hosted by the Blood Bank Guy at www.bbguy.org.
Varia
Visit www.fnaitcompanion.com, an educational website provided by Johnson & Johnson. Dedicated to both patient and professional education, it also offers a great newsletter to keep you informed about the latest publications in this field.
